Shortening vaccine development, which normally has a multi-year cycle. Wisconsin has expertise in this area through its research universities and private companies such as Madison’s FluGen. Co-founders Yoshihiro Kawaoka and Gabriele Neumann are known around the world for their past anti-viral work, which is why FluGen was approached by an India-based firm, Bharat Biotech, which has developed 16 vaccines in the past, to take part in a larger vaccine development project that also involves the UW-Madison.